Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 30:13:25158414211022882.
doi: 10.1177/25158414211022882. eCollection 2021 Jan-Dec.

Hemoglobinopathies: ocular manifestations in children and adolescents

Affiliations
Review

Hemoglobinopathies: ocular manifestations in children and adolescents

Omar Moussa et al. Ther Adv Ophthalmol. .

Abstract

Hemoglobinopathies are genetic disorders that lead to abnormal structure of the hemoglobin molecule. Sickle cell disease, the most common inherited blood disorder, is characterized by defective oxygen transport. Almost every part of the eye can be affected by sickle cell disease; however, proliferative sickle cell retinopathy is the primary cause of vision loss, either from vitreous hemorrhage or retinal detachment. Here we review the various manifestations of hemoglobinopathies on the eyes of children and adolescents, with a specific focus on sickle cell disease and its different phenotypes. Newer, more sensitive ophthalmological imaging modalities, including ultra-widefield fluorescein angiography, spectral-domain optical coherence tomography, and optical coherence tomography angiography, are available. These sensitive modalities allow for a more thorough examination of the retinal periphery where sickle cell retinopathy is often present. Utilization of such modalities will help with the early detection of the disease in children, which provide a better understanding of the pathogenesis of the disease and guide future screening and treatment regimens.

Keywords: hemoglobinopathies; ocular manifestations; sickle cell disease; sickle cell retinopathy.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: RWSC is a consultant for Carl Zeiss Meditec, Inc.

Figures

Figure 1.
Figure 1.
A widefield fundus photograph showing multiple salmon-patch hemorrhages (white arrows) as a result of peripheral arteriolar occlusion in a patient with sickle cell disease.
Figure 2.
Figure 2.
Ultra-widefield fluorescein angiography showing large areas of peripheral non-perfusion (yellow asterisks), arteriolar occlusion (red arrow), and arteriovenous anastomosis (blue arrow) in a patient with sickle cell retinopathy.
Figure 3.
Figure 3.
Ultra-widefield fluorescein angiography (left) and widefield fundus photography showing an area of sea-fan neovascularization (white arrow) surrounded by retinal laser photocoagulation marks (asterisks) in a patient with sickle cell retinopathy (Goldman stage III).
Figure 4.
Figure 4.
Optical coherence tomography angiography demonstrating decreased vascular density (asterisk) in the superficial capillary plexus (a) and deep capillary plexus (b). Areas of vascular loss correspond to temporal macular thinning (white arrow) shown on spectral-domain optical coherence tomography (c).

Similar articles

Cited by

References

    1. Keber B, Lam L, Mumford J, et al.. Hematologic conditions: common hemoglobinopathies. FP Essent 2019; 485: 24–31. - PubMed
    1. Kohne E. Hemoglobinopathies: clinical manifestations, diagnosis, and treatment. Dtsch Arztebl Int 2011; 108: 532–540. - PMC - PubMed
    1. Phanmany S, Chanprasert S. Molecular prevalence of thalassemia and hemoglobinopathies among the Lao Loum Group in the Lao People’s Democratic Republic. Int J Lab Hematol 2019; 41: 650–656. - PubMed
    1. Steinberg MH. Review: sickle cell disease: present and future treatment. Am J Med Sci 1996; 312: 166–174. - PubMed
    1. Steinberg MH. In the clinic. Sickle cell disease. Ann Intern Med 2011; 155: ITC31–ITC316. - PubMed

LinkOut - more resources